Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
06/2003
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0906272B1 Peptides
06/03/2003US6573399 Synthesis of α-amino-α′, α′-dihaloketones and process for the preparation of β-amino acid derivatives by the use of the same
06/03/2003US6573388 Synthetic intermediates for the synthesis of HIV protease inhibitors and oligopeptide mimetics
06/03/2003US6573297 (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same
06/03/2003US6573284 Method of treating melanoma
05/2003
05/30/2003WO2003043974A2 New pharmaceutical compounds
05/30/2003WO2003018552A3 Aromatic and heteroaromatic acid halides for synthesizing polyamides
05/30/2003WO2002094765A3 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
05/30/2003CA2467166A1 New pharmaceutical compounds
05/29/2003US20030100796 Reacting a 3-oxazolidin-5-one derivative with a halomethyl lithium and then treating with an acid
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030100512 Gamma-secretase inhibitors
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1313560A1 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6570039 Process for producing α-aminoketones
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6570020 Reacting 2-(3,3,3-trifluoropropyl),2-hydroxy,4a-benzyl-7-carboxy-1,2,3,4,4a,9,10,10a -octahydrophenanthrene with 2-methyl-3-(aminomethyl)pyridine to form the corresponding pyridyl-substituted amide at position 7
05/27/2003US6569899 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
05/27/2003US6569810 Cyclopentane-1,3-dione derivatives
05/27/2003US6569411 Deodoring, microbiocides, marking odors
05/22/2003WO2003042150A1 Novel bensophenone derivatives or salts thereof
05/22/2003WO2002044144A3 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
05/22/2003WO2002026705A8 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
05/22/2003US20030097011 Novel carbamate-based cationic lipids
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/21/2003EP1311477A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311345A1 Biphasic reaction vessel and methods of use
05/21/2003EP0827943B1 Processes for the reduction of carbonyl compounds
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566476 Addition polymers; coatings, inks, detergents, papermaking
05/20/2003CA2197302C Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2002000611A8 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists
05/15/2003US20030092931 For latex; stable suspension
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092634 Novel compounds and compositions as protease inhibitors
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1310482A1 Prodrugs of excitatory amino acids
05/14/2003EP1310480A1 Prodrugs of excitatory amino acids
05/14/2003EP1309583A2 Process for preparing discodermolide and analogues thereof
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309535A1 A PROCESS FOR THE PREPARATION OF $g(a)' CHLOROKETONES
05/14/2003EP1119545B1 Carbamate-functional allyl monomers and polymers therefrom
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1417204A Solvent process of preparing N-methyl-2-naphthyl carbamate
05/14/2003CN1417203A Prepn of N-methyl-2-naphthyl carbamate
05/14/2003CN1108288C Benzyloxy substituted aromatics and their use as fungicides
05/13/2003US6563003 Process to produce amino alcohol salts
05/13/2003US6562989 Catalyst for aromatic C—O, C—N, and C—C bond formation
05/13/2003US6562977 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates
05/13/2003US6562967 Drug screening; purity
05/13/2003US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003CA2126461C Novel acid anhydrides and preparation and use thereof
05/08/2003WO2002076928A3 Alkylamine derivatives as antifouling agents
05/08/2003WO2002048097A9 Compounds, compositions and methods for treatment of parasitic infections
05/08/2003WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
05/08/2003US20030088099 Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
05/08/2003US20030087934 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087828 Peptide derivatives and pharmaceutically acceptable salts, thereof, processes for preparation of both, and use thereof
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/07/2003EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides
05/07/2003EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1162949A4 Urethane surfactants and their use in personal care formulations
05/07/2003CN1416346A Peotease inhibitors
05/06/2003US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
05/06/2003US6559261 A method for producing a polymeric material, said method comprising subjecting a starting material which includes two multiple bonds which are activated so that they will take part in a polymerisation reaction and wherein the multiple bonds
05/02/2003EP1306371A1 Cyclic imines
05/02/2003EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003WO2002098843A3 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
05/01/2003US20030083519 Glycyl lysine derivatives bound to a central aromatic linking core; angiogenesis inhibitors; antitumor agents; induction of apoptosis; bind to integrin alpha v beta 3 and block its interaction with matrix metalloproteinases
05/01/2003US20030083503 Synthesis of acylated keto amides from sulfonyl amides
05/01/2003US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
05/01/2003US20030083356 Statine derivatives for the treatment of Alzheimer's disease
05/01/2003US20030083353 Beta-secretase inhibitors
05/01/2003US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030080320 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
04/2003
04/30/2003CN1414949A Process for synthesis of palycarbamates
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1413984A Diquaternary-base diphenyl surface reactive agent and its preparation process
04/30/2003CN1107052C Process for preparing aminoformate compounds with CO2 instead of severely toxic optical gas
04/29/2003US6555596 Multifunctional allyl carbamates and coatings therefrom
04/29/2003US6555580 Treating arteriosclerosis and hypercholesterolaemia
04/29/2003US6555572 Benzylated PDE4 inhibitors
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 157